Doctor profile · Federal record
Dr. John Bishay, M.D.
Urology Physician (CMS: Urology) · Omaha, NE
- NPI 1992933758
- Accepts Medicare
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
111 S 90Th St
Omaha, NE 681143907
(402) 397-9800
fax (402) 397-7591
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- June 17, 2015
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 208800000X — NUCC code
- State license (1)
- Nebraska #28462
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992933758. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,722
Distinct HCPCS
10
Medicare allowed
$561,386
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 6,960 | 30 | $23 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,436 | 38 | $0 | |
J1952 |
Leuprolide injectable, camcevi, 1 mg | 1,638 | 22 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 637 | 430 | $117 | |
81003 |
Automated urinalysis test | 481 | 369 | $2 | |
36415 |
Insertion of needle into vein for collection of blood sample | 397 | 260 | $8 | |
84153 |
Psa (prostate specific antigen) measurement, total | 295 | 216 | $18 | |
51798 |
Ultrasound measurement of bladder capacity after voiding | 270 | 204 | $10 | |
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg | 159 | 35 | $175 | |
52000 |
Diagnostic exam of bladder and urethra using an endoscope | 128 | 104 | $71 |
In context: peer comparison
Among 16 peers in Omaha Urology Physician, average services per provider: 268. This provider delivers 59× the peer median.Open Payments
Industry payments received
All-time total
$20,682
Transactions
50
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $16,217.08 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $1,458.00 | |
| Janssen Scientific Affairs, LLC | 1 | $1,090.00 | |
| Intuitive Surgical, INC. | 5 | $762.55 | |
| Janssen Biotech, INC. | 10 | $274.84 | |
| Urogen Pharma, INC. | 2 | $256.75 | |
| Procept BioRobotics Corporation | 2 | $141.67 | |
| Accord Healthcare, INC. | 3 | $84.49 | |
| Edap Technomed INC | 3 | $78.00 | |
| Boston Scientific Corporation | 2 | $59.95 | |
| Astellas Pharma US INC | 3 | $59.55 | |
| Abbvie INC. | 3 | $54.41 | |
| Sumitomo Pharma America, INC. | 2 | $36.36 | |
| Ge Healthcare | 1 | $21.75 | |
| Teleflex LLC | 1 | $20.41 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,942
Patients
457
Total drug cost
$1,948,041
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tamsulosin Hcl | Generic | 701 | 200 | $15,293 |
| Finasteride | Generic | 282 | 81 | $5,282 |
| Myrbetriq (Mirabegron) | Brand | 175 | 37 | $106,348 |
| Oxybutynin Chloride ER (Oxybutynin Chloride) | Brand | 160 | 37 | $5,246 |
| Prednisone | Generic | 159 | 25 | $1,421 |
| Abiraterone Acetate | Generic | 151 | 21 | $512,345 |
| Xtandi (Enzalutamide) | Brand | 68 | 0 | $789,532 |
| Nubeqa (Darolutamide) | Brand | 40 | 0 | $482,214 |
| Gemtesa (Vibegron) | Brand | 39 | 12 | $20,681 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 37 | 33 | $322 |
Hospital affiliations
Frequently asked questions
What is Dr. John Bishay's medical specialty?
Dr. John Bishay practices Urology Physician in Omaha, NE.
Where does Dr. John Bishay practice?
Dr. John Bishay practices at 111 S 90Th St, Omaha, NE 681143907. Office phone: 4023979800.
What is Dr. John Bishay's NPI?
Dr. John Bishay's National Provider Identifier (NPI) is 1992933758, issued by NPPES.
Does Dr. John Bishay accept Medicare assignment?
Yes. Dr. John Bishay accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Bishay commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Leuprolide injectable, camcevi, 1 mg (HCPCS J1952). Source: CMS Medicare Physician & Other Practitioners file.